NEU3 and neoplasm: Their results indicated that NEU3 functioned in tumorigenesis via the EGFR/Src signaling pathway and led them to posit that inhibiting NEU3 might be a treatment option for delaying tumor growth by cells expressing GM3 as their major ganglioside.